Atherosclerosis in systemic autoimmune diseases. Early markers and risk factor
PhD ceremony: Mr. H.L.A. Nienhuis, 11.00 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Atherosclerosis in systemic autoimmune diseases. Early markers and risk factor
Promotor(s): prof. C.G.M. Kallenberg
Faculty: Medical Sciences
Systemic autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and granulomatosis with polyangiitis, are associated with an increased prevalence of cardiovascular disease (CVD), due to accelerated atherosclerosis. We studied early markers and potential risk factors for atherosclerosis in systemic autoimmune diseases. Pulse wave analysis (PWA) measures small artery elasticity (SAE) and was used as marker for EC function. SAE was decreased in patients with systemic autoimmune disease without overt atherosclerosis. Accumulation of advanced glycation end products (AGEs) was increased in patients with systemic autoimmune diseases and was related to SAE and intima media thickness, as marker for early atherosclerosis. Polymorphisms in the gene for the receptor for advanced glycation end products (RAGE) were associated with disease susceptibility for SLE and RA and were associated with cardiovascular disease and disease severity in RA. PWA is a sensitive method to detect early vascular changes in patients with systemic autoimmune diseases. AGEs and their receptor RAGE contribute to accelerated atherosclerosis in systemic autoimmune diseases. Prospective studies are necessary to establish whether decreased SAE is indeed an early marker for atherosclerosis and whether interventions to reduce accumulation of AGEs can suppress the development of atherosclerosis in patients with systemic autoimmune diseases.
Last modified: | 13 March 2020 12.59 a.m. |
More news
-
29 November 2023
UMCG opent nieuwe faciliteit voor microbioomonderzoek 
Vandaag opent het UMCG de Groningen Microbioom Hub: een nieuwe faciliteit met state-of-the-art technologie waarin alle UMCG-expertise op het gebied van microbioomonderzoek samenkomt. Dit zorgt voor unieke mogelijkheden in onderzoek en maakt nieuwe...
-
28 November 2023
Science: more exciting than showbiz
Science often seems very complicated. Most people probably don't really know what researchers do, and what it takes to make a breakthrough. That is why it is important to keep the general public informed of what is happening in science, says Iris...
-
13 November 2023
UMCG beantwoordt vragen patiënten met hulp van AI
Het UMCG zet kunstmatige intelligentie (artificial intelligence, afgekort AI) in om zorgverleners te helpen bij het beantwoorden van schriftelijke vragen van patiënten. Dit gebeurt in samenwerking met andere ziekenhuizen vanuit de EPIC Nederlandse...